COMPANY
IPSEN LIMITED
IPSEN LIMITED: marketing authorisation holder for Lanreotide, Triptorelin, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Lanreotide | LANREOTIDE IPSEN 120 MG, SOLUTION FOR INJECTION IN A PREFILLED SYRINGE, PL 34926/0007, Authorised Regulator MHRA |
|---|---|
| Lanreotide | LANREOTIDE IPSEN 60 MG, SOLUTION FOR INJECTION IN A PREFILLED SYRINGE, PL 34926/0005, Authorised Regulator MHRA |
| Lanreotide | LANREOTIDE IPSEN 90 MG, SOLUTION FOR INJECTION IN A PREFILLED SYRINGE, PL 34926/0006, Authorised Regulator MHRA |
| Triptorelin | DECAPEPTYL SR 11.25 MG, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION, PL 34926/0003, Authorised Regulator MHRA |
| Triptorelin | DECAPEPTYL SR 22.5MG POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION., PL 34926/0013, Authorised Regulator MHRA |
| Triptorelin | DECAPEPTYL SR 3MG, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION, PL 34926/0002, Authorised Regulator MHRA |
| Triptorelin | SALVACYL 11.25MG POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION, PL 34926/0012, Authorised Regulator MHRA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.